<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04005326</url>
  </required_header>
  <id_info>
    <org_study_id>N-144-2018</org_study_id>
    <nct_id>NCT04005326</nct_id>
  </id_info>
  <brief_title>Quadratus Lumborum Block Versus Fascia Iliaca Block for Hip Arthroplasty</brief_title>
  <official_title>Quadratus Lumborum Block Versus Fascia Iliaca Block for Hip Arthroplasty: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bassant M. Abdelhamid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Quadratus lumborum block is a newly developed block with good performance in lower abdominal
      surgery. In a cadaveric study, the spread of local anesthetic in the anterior approach of QL
      block (QL3) was reported to cover nerve roots from T10 to L3. Thus, it was hypothesized that
      this approach could be used in hip surgeries with minimal motor affection.

      This study aims to compare QL3 block and suprainguinal Fascia Iliaca block in the duration of
      postoperative analgesia, pain scores, motor power in quadriceps muscle, and side effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, controlled, double blinded, trial will be conducted in Cairo university
      hospital. Written informed consent will be obtained from all participants. Randomization will
      be achieved using a computer-generated sequence. Concealment will be achieved using opaque
      envelopes. Patients scheduled for hip replacement surgeries under subarachnoid block (SAB).
      e.g. hip hemiarthroplasty, total hip arthroplasty.

      On arrival of the patients to regional anesthesia room, patients will be secured with
      18-gauge intravenous cannula, and will receive ondansetron (4 mg), and dexamethasone (8 mg
      IV). Monitoring will include Electrocardiography, non-invasive arterial blood pressure, and
      pulse oximetry.

      Before receiving subarachinoid block, patients will be randomly assigned into one of the two
      study groups:

      QLB Group (n=17): this group will receive ultrasound-guided transmuscular quadratus lumborum
      block; (Anterior QLB or QLB III) FIB Group (n=17): this group will receive suprainguinal
      fascia iliaca block To achieve double blinding, patients will receive the block with 30 mL
      bupivacaine (0.25%) by the anesthetist. Another doctor not involved in the block procedure
      will evaluate the patients postoperative.

      After finishing the block &amp; assessment of motor power of quadriceps femoris muscle , patient
      will receive midazolam (2mg intravenous), and then transferred to operation room.

      Postoperatively, all patients will receive 1 g paracetamol every 6 hours and 30 mg ketorolac
      every 12 hours.

      If the visual analogue scale (VAS) is 4 or more, a 2 mg morphine increment will be added per
      time to maintain a resting VAS at &lt;3 with maximum total 24-hours morphine 10 mg.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2019</start_date>
  <completion_date type="Anticipated">October 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 5, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of analgesia</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>If the visual analogue scale (VAS) is 4 or more, a 2 mg morphine increment will be added per time to maintain a resting VAS at &lt;3 with maximum total 24-hours morphine 10 mg.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Static visual analogue pain scale</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>Visual analogue pain scale (VAS) at rest. The pain visual analogue pain scale( VAS) is a continuous scale 10 centimeters (100 mm) in length. The scale is most commonly anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 100 [100‐mm scale]).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dynamic visual analogue pain scale</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>Visual analogue pain scale (VAS) on movement. The pain visual analogue pain scale( VAS) is a continuous scale 10 centimeters (100 mm) in length. The scale is most commonly anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 100 [100‐mm scale]).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset of sensory block of quadratus lumborum block and fascia iliaca block</measure>
    <time_frame>30 minutes</time_frame>
    <description>the time interval between the injection of the study medication till complete loss of sensation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first postoperative analgesic request</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>morphine increment will be added per time to maintain a resting VAS at &lt;3 with maximum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total morphine requirements</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>If the visual analogue scale (VAS) is 4 or more, a 2 mg morphine increment will be added per time to maintain a resting VAS at &lt;3 with maximum total 24-hours morphine 10 mg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the quadriceps muscle power.</measure>
    <time_frame>24 hours</time_frame>
    <description>the patient will be in supine position and the patient's knee will be fully flexed, and the patient will be asked to extend it. The motor block is classified as follows: grade 0; normal muscle power, grade I; motor weakness, grade II; complete motor paralysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time needed to perform the block</measure>
    <time_frame>30 minutes</time_frame>
    <description>the total time of the procedure (quadratus lumborum block or fascia iliaca block) started from patient positioning till completion of local anesthesia injection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of pain during positioning for spinal block</measure>
    <time_frame>30 minutes</time_frame>
    <description>to assess the ability of either two types of the the blocks to relieve pain during positioning for spinal anesthesia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>QLB Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this group will receive ultrasound-guided transmuscular quadratus lumborum block; (Anterior QLB or QLB III)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FIB Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this group will receive suprainguinal fascia iliaca block</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quadratus lumborum block; (Anterior QLB or QLB III)</intervention_name>
    <description>The patient will be in the lateral position. A low frequency convex probe will be vertically attached above the iliac crest and a needle will be inserted in plane from the posterior edge of the convex probe through the quadratus lumborum in an anteromedial direction. The needle tip will be placed between the psoas major muscle and the quadratus lumborum muscle. After negative aspiration, 30 mL of 0.25 % of bupivacaine will be injected into the fascial plane incrementally, aspirating every 5 ml.</description>
    <arm_group_label>QLB Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>suprainguinal fascia iliaca block</intervention_name>
    <description>In supine position, a high frequency linear probe will be placed in the inguinal crease. Scan starting laterally from the femoral artery and nerve in inguinal crease to identify the sartorius muscle, tracing the muscle until it's origin to anterior superior iliac spine. The shadow of the bony of iliac crest &amp; iliacus muscle will be seen, the end point of the injection is deep to the fascia iliaca and above the iliacus muscle in the lateral part of the iliacus muscle. After negative aspiration, 30 mL of 0.25 % of bupivacaine will be injected under the fascial plane incrementally, aspirating every 5 ml.</description>
    <arm_group_label>FIB Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subarachnoid block</intervention_name>
    <description>Patients will receive SAB using 25g spinal needle in the lateral position. Fifteen milligrams of hyperbaric bupivacaine will be administered at L3-L4 or at L4-L5 interspace in addition to 25 mcg fentanyl with rapid crystalloid co-load.
Spinal anesthesia will be considered successful when a bilateral block to T12, as assessed by loss of cold (cold ice) and pain (a 23-gauge needle) sensations, will be established 10 -minutes after the intrathecal injection. If spinal anesthesia failed, such patients will be administered general anesthesia and will be excluded from this study.</description>
    <arm_group_label>FIB Group</arm_group_label>
    <arm_group_label>QLB Group</arm_group_label>
    <other_name>spinal anesthesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for hip replacement surgeries under subarachnoid block (SAB). e.g.
             hip hemiarthroplasty, total hip arthroplasty.

        Exclusion Criteria:

          -  Coagulopathy, infection at the injection site,.

          -  Allergy to local anesthetics.

          -  Severe cardiopulmonary disease (≥ASA IV),.

          -  Diabetic or other neuropathies.

          -  Patients receiving opioids for chronic analgesic therapy.

          -  Contraindication to spinal anesthesia.

          -  Inability to comprehend visual analogue scale (VAS).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed M. Hasanin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmed M. Hasanin, M.D.</last_name>
    <phone>+201095076954</phone>
    <email>ahmedmohamedhasanin@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mahmoud swilem</last_name>
    <phone>+201008855731</phone>
    <email>mr.sewilam@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Anesthesia Department</name>
      <address>
        <city>Cairo</city>
        <zip>1772</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bassant abdelhamid, M.D.</last_name>
      <phone>01224254012</phone>
      <email>bassantmohamed197@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Ahmed Hassanin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mahmoud Swilem</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Bullock WM, Yalamuri SM, Gregory SH, Auyong DB, Grant SA. Ultrasound-Guided Suprainguinal Fascia Iliaca Technique Provides Benefit as an Analgesic Adjunct for Patients Undergoing Total Hip Arthroplasty. J Ultrasound Med. 2017 Feb;36(2):433-438. doi: 10.7863/ultra.16.03012. Epub 2016 Dec 10.</citation>
    <PMID>27943417</PMID>
  </reference>
  <reference>
    <citation>Kadam VR. Ultrasound-guided quadratus lumborum block as a postoperative analgesic technique for laparotomy. J Anaesthesiol Clin Pharmacol. 2013 Oct;29(4):550-2. doi: 10.4103/0970-9185.119148.</citation>
    <PMID>24249997</PMID>
  </reference>
  <reference>
    <citation>Ueshima H, Otake H, Lin JA. Ultrasound-Guided Quadratus Lumborum Block: An Updated Review of Anatomy and Techniques. Biomed Res Int. 2017;2017:2752876. doi: 10.1155/2017/2752876. Epub 2017 Jan 3. Review.</citation>
    <PMID>28154824</PMID>
  </reference>
  <reference>
    <citation>Bang S, Chung J, Jeong J, Bak H, Kim D. Efficacy of ultrasound-guided fascia iliaca compartment block after hip hemiarthroplasty: A prospective, randomized trial. Medicine (Baltimore). 2016 Sep;95(39):e5018. doi: 10.1097/MD.0000000000005018.</citation>
    <PMID>27684871</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>June 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2019</study_first_posted>
  <last_update_submitted>July 5, 2019</last_update_submitted>
  <last_update_submitted_qc>July 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Bassant M. Abdelhamid</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

